Bainbridge Island, WA, United States of America

Michael Wittekind

USPTO Granted Patents = 24 (Patent Applications = 10)

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 8 (Patent Applications = 7)

Average Co-Inventor Count = 4.0

ph-index = 9

Forward Citations = 578(Granted Patents)

Location History:

Doylestown, PA (US) (2001 - 2004)
New Canaan, CT (US) (2016 - 2020)
Bainbridge Island, WA (US) (2010 - 2022)
Yonkers, NY (US) (2017 - 2023)

Company Filing History:

11 out of 16

Contrafect Corporation

patents

9 out of 3,681

Bristol-myers Squibb Compnay

Trellis Bioscience, Inc.

patents

5. 1 out of 2

Aurobac Therapeutics Sas

patents

6. 1 out of 1,991

The State University of New York

patents

where one patent can have more than one assignee

Years Active: 2001-2024

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12144845 - Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby (2024-11-19),

2. 11827693 - Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy (2023-11-28),

3. 11524046 - Biofilm prevention, disruption and treatment with bacteriophage lysin (2022-12-13),

4. 11413334 - Lysin polypeptides active against Gram-negative bacteria (2022-08-16),

5. 11357833 - Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby (2022-06-14),

6. 11246928 - Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof (2022-02-15),

7. 10995131 - Libraries of modified fibronectin type III tenth domain-containing polypeptides (2021-05-04),

8. 10813983 - Bacteriophage lysin and antibiotic combinations against gram positive bacteria (2020-10-27),

9. 10744189 - Lysin polypeptides active against Gram-negative bacteria (2020-08-18),

10. 10639370 - Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof (2020-05-05),

11. 9889181 - Bacteriophage lysin and antibiotic combinations against gram positive bacteria (2018-02-13),

12. 9862758 - Inhibitors of type 2 vascular endothelial growth factor receptors (2018-01-09),

13. 9718875 - Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy (2017-08-01),

14. 9499594 - Biofilm prevention, disruption and treatment with bacteriophage lysin (2016-11-22),

15. 9328157 - Inhibitors of type 2 vascular endothelial growth factor receptors (2016-05-03),

Title: The Innovative Journey of Michael Wittekind

Introduction: Michael Wittekind, a talented inventor based in Bainbridge Island, WA (US), has made significant contributions to the field of technology through his creative and groundbreaking inventions.

Latest Patents: Michael Wittekind holds several patents in various technological domains, showcasing his versatility and ingenuity in the innovation landscape.

Career Highlights: With a career spanning over two decades, Michael Wittekind has been at the forefront of technological advancements, consistently pushing the boundaries of what is possible. His dedication to innovation has led to the development of cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Michael Wittekind has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. These collaborations have not only enhanced the impact of his work but have also paved the way for future innovations.

Conclusion: Michael Wittekind's passion for innovation, coupled with his relentless pursuit of excellence, has established him as a prominent figure in the world of inventors. His contributions have not only transformed industries but have also inspired the next generation of innovators to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.